Vasantha Jotwani

ORCID: 0000-0003-1913-3957
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV-related health complications and treatments
  • HIV/AIDS drug development and treatment
  • Chronic Kidney Disease and Diabetes
  • Dialysis and Renal Disease Management
  • HIV/AIDS Research and Interventions
  • Blood Pressure and Hypertension Studies
  • Sepsis Diagnosis and Treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Acute Kidney Injury Research
  • COVID-19 Clinical Research Studies
  • Metabolism and Genetic Disorders
  • HIV Research and Treatment
  • Folate and B Vitamins Research
  • COVID-19 and healthcare impacts
  • Organ Transplantation Techniques and Outcomes
  • Renal Transplantation Outcomes and Treatments
  • Intensive Care Unit Cognitive Disorders
  • Mitochondrial Function and Pathology
  • Heart Failure Treatment and Management
  • Cardiac Ischemia and Reperfusion
  • Hormonal Regulation and Hypertension
  • Liver Disease and Transplantation
  • Renal Diseases and Glomerulopathies
  • Muscle and Compartmental Disorders
  • Venous Thromboembolism Diagnosis and Management

University of California, San Francisco
2015-2024

San Francisco VA Health Care System
2017-2024

San Francisco VA Medical Center
2011-2023

University of California System
2011

Chronic kidney disease (CKD) causes substantial global morbidity and increases cardiovascular all-cause mortality. Unlike other chronic diseases with established strategies for screening, there has been no consensus on whether health systems governments should prioritize early identification intervention CKD. Guidelines evaluating managing CKD are available but have not universally adopted in the absence of incentives or quality measures prioritizing care. The burden falls disproportionately...

10.1016/j.kint.2020.10.012 article EN cc-by-nc-nd Kidney International 2020-10-27
Michael G. Shlipak Anoop Sheshadri Fang‐Chi Hsu Shyh‐Huei Chen Vasantha Jotwani and 95 more Gregory J. Tranah Roger A. Fielding Christine K. Liu Joachim H. Ix Steven G. Coca Marco Pahor Jack M. Guralnik Christina Leeuwenburgh Connie Caudle Lauren Crump Latonia Holmes Jocelyn Leeuwenburgh Ching-ju Lu Michael E. Miller Mark A. Espeland Walter T. Ambrosius William B. Applegate Daniel P. Beavers Robert P. Byington Delilah Cook Curt D. Furberg Lea N. Harvin Leora Henkin John Hepler Fang‐Chi Hsu Laura Lovato Wesley Roberson Julia Rushing Scott Rushing Cynthia L. Stowe Michael P. Walkup Don Hire W. Jack Rejeski Jeffrey A. Katula Peter H. Brubaker Shannon L. Mihalko Janine M. Jennings Evan C. Hadley S Romashkan Kushang V. Patel Denise E. Bonds Mary Mcdermott Bonnie Spring Michelle E. Hauser Diana Kerwin Kathryn Domanchuk Rex Graff Alvito Rego Timothy S. Church Steven N. Blair Valerie H. Myers Ron Monce Nathan E. Britt Melissa Harris Ami Parks McGucken Ruben Rodarte Heidi K. Millet Catrine Tudor‐Locke Ben P. Butitta Sheletta G. Donatto Shannon Cocreham ­Abby C. King Cynthia M. Castro William L. Haskell Randall S. Stafford Leslie A. Pruitt Kathy Berra Veronica Yank Roger A. Fielding Miriam E. Nelson Sara C. Folta Edward M. Phillips Christine K. Liu Erica McDavitt Kieran F. Reid Dylan Kirn Evan Pasha Won S. Kim Vince E. Beard Eleni X. Tsiroyannis Cynthia Hau Todd M. Manini Stephen D. Anton Susan Nayfield Thomas W. Buford Michael Marsiske Bhanuprasad Sandesara Jeffrey D. Knaggs Megan S. Lorow William C. Marena Irina Korytov Holly L. Morris Margo Fitch Floris Singletary Jackie Causer

Observational evidence suggests that higher physical activity is associated with slower kidney function decline; however, to our knowledge, no large trial has evaluated whether and exercise can ameliorate decline in older adults.

10.1001/jamainternmed.2022.1449 article EN JAMA Internal Medicine 2022-05-02

eGFR and albuminuria primarily reflect glomerular function injury, whereas tubule cell atrophy interstitial fibrosis on kidney biopsy are important risk markers for CKD progression. Kidney injury have been studied in hospitalized AKI. Here, we examined the association between urinary at baseline with subsequent loss of persons nondiabetic who participated Systolic Blood Pressure Intervention Trial (SPRINT).Among 2428 SPRINT participants (eGFR<60 ml/min per 1.73 m2) baseline, measured urine...

10.2215/cjn.02780319 article EN Clinical Journal of the American Society of Nephrology 2020-02-28

Abstract Aims Biomarkers of kidney tubule injury, inflammation and fibrosis have been studied extensively established as risk markers adverse cardiovascular disease (CVD) outcomes. However, associations tubular function with clinical events not well studied, especially in persons chronic (CKD). Methods results Using a sample 2377 CKD at the baseline Systolic Blood Pressure Intervention Trial (SPRINT) visit, we evaluated association three urine markers, alpha-1 microglobulin (α1m), beta-2...

10.1093/eurheartj/ehz392 article EN European Heart Journal 2019-05-22

Despite advances in therapy, HIV-infected individuals remain at higher risk for kidney dysfunction than uninfected individuals. It was hypothesized that urine levels of α1-microglobulin, a biomarker proximal tubular dysfunction, would predict function decline and mortality women.In the Women's Interagency HIV Study, α1-microglobulin creatinine concentrations were measured 903 287 women using stored from 1999 to 2000, when prevalence tenofovir use <1%. Participants categorized into three...

10.2215/cjn.03220314 article EN Clinical Journal of the American Society of Nephrology 2014-11-05

Cardiovascular risk remains high in kidney transplant recipients (KTRs) despite improved function after transplant. Urinary markers of fibrosis and injury may help to reveal mechanisms this risk. In a case–cohort study among stable KTRs who participated the FAVORIT trial, we measured four urinary proteins known correlate with tubulointerstitial on biopsy (urine alpha 1 microglobulin [α1m], monocyte chemoattractant protein-1 [MCP-1], procollagen type I [PINP] III [PIIINP] N-terminal amino...

10.1111/ajt.14284 article EN cc-by-nc-nd American Journal of Transplantation 2017-03-29

Chronic kidney disease is a strong risk factor for cardiovascular (CVD), but clinical measures (estimated glomerular filtration rate and albuminuria) do not fully reflect the multiple aspects of tubules influencing health. Applied methods are needed to integrate numerous tubule biomarkers into useful prognostic scores. In SPRINT (Systolic Blood Pressure Intervention Trial) participants with chronic at baseline cr&amp;cys &lt;60 mL/minute per 1.73 m 2 ), we measured 8 from urine (α1M [α1M...

10.1161/hypertensionaha.119.13339 article EN Hypertension 2019-08-05

Kidney tubular atrophy on biopsy is a strong predictor of chronic kidney disease (CKD) progression, but health poorly quantified by traditional measures including estimated glomerular filtration rate (eGFR) and albuminuria. We hypothesized that urinary biomarkers impaired tubule function would be associated with faster eGFR declines in persons CKD.We measured baseline urine concentrations uromodulin, β2-microglobulin (β2m), α1-microglobulin (α1m) among 2,428 participants the Systolic Blood...

10.1159/000509978 article EN American Journal of Nephrology 2020-01-01

Tenofovir disoproxil fumarate (tenofovir) is associated with elevated concentrations of biomarkers kidney damage and dysfunction in individuals HIV. The relationship these longitudinal function decline unknown.We evaluated associations 14 urinary injury changes eGFR among 198 men women HIV who initiated tenofovir between 2009 2015 the Multicenter AIDS Cohort Study Women's Interagency Study. Urinary included albumin-to-creatinine ratio, α-1-microglobulin, β-2-microglobulin, cystatin C,...

10.2215/cjn.01700218 article EN Clinical Journal of the American Society of Nephrology 2018-08-28

Background The antiretroviral medication, tenofovir disoproxil fumarate ( TDF ), is used by most human immunodeficiency virus–infected persons in the United States despite higher risks of chronic kidney disease. Although disease a strong risk factor for heart failure HF association with incident unclear. Methods and Results We identified 21 435 patients Veterans Health Administration actively using antiretrovirals between 2002 2011. excluded prior diagnosis . was analyzed categorically...

10.1161/jaha.116.005387 article EN cc-by-nc-nd Journal of the American Heart Association 2017-04-05

Pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) is becoming increasingly adopted for HIV prevention. Tenofovir can cause proximal tubular damage chronic kidney disease in HIV-infected persons, but little known regarding its nephrotoxic potential among HIV-uninfected persons. In this study, we evaluated the effects of PrEP on urine levels following: α1-microglobulin (α1m), a marker impaired reabsorption; albuminuria, measure glomerular injury;...

10.1097/qai.0000000000001654 article EN JAIDS Journal of Acquired Immune Deficiency Syndromes 2018-02-21

Kidney tubulointerstitial fibrosis on biopsy is a strong predictor of chronic kidney disease (CKD) progression, and CKD associated with elevated risk cardiovascular (CVD). Tubular health poorly quantified by traditional function measures, including estimated glomerular filtration rate (eGFR) albuminuria. We hypothesized that urinary biomarkers tubular injury, inflammation, repair would be higher CVD mortality in persons CKD.We measured concentrations interleukin-18 (IL-18), injury...

10.1159/000499531 article EN American Journal of Nephrology 2019-01-01

In HIV-infected women, urine concentrations of novel tubulointerstitial injury markers, interleukin-18 (IL-18) and kidney marker-1 (KIM-1), are associated with function decline all-cause mortality. We hypothesized that individuals preserved filtration would have more extensive injury, as determined by compared to the uninfected controls, risk factors for differ from albuminuria.In this cross-sectional study, we IL-18, KIM-1 albumin-to-creatinine ratio (ACR) in 908 289 HIV-uninfected women...

10.3851/imp2677 article EN Antiviral Therapy 2013-08-23

Although individual urine biomarkers are associated with chronic kidney disease (CKD) incidence and all-cause mortality in the setting of HIV infection, their combined utility for prediction remains unknown.We measured eight shown previously to be incident CKD risk among 902 HIV-infected women Women's Interagency Study: N-acetyl-β-d-glucosaminidase (NAG), injury molecule-1 (KIM-1), alpha-1 microglobulin (α1m), interleukin 18, neutrophil gelatinase-associated lipocalin, albumin-to-creatinine...

10.1093/ndt/gfv426 article EN public-domain Nephrology Dialysis Transplantation 2016-01-10

Chronic kidney disease (CKD) is common among HIV-infected individuals but serum creatinine insensitive for detecting damage at early stages. We hypothesized that HIV infection would be associated with elevations in subclinical markers of injury and fibrosis a contemporary cohort men.In this cross-sectional study, we measured urine levels interleukin-18 (IL-18), molecule-1 (KIM-1), pro-collagen type III N-terminal pro-peptide (PIIINP) albumin-creatinine ratio (ACR) 813 331 uninfected men...

10.3851/imp3124 article EN Antiviral Therapy 2016-07-01

Tenofovir disoproxil fumarate (TDF) can cause kidney damage, but current clinical tests are insensitive for detecting toxicity. Among 884 HIV-infected men enrolled in the Multicenter AIDS Cohort Study, we measured urine biomarkers specific tubular damage (interleukin-18, injury molecule-1, procollagen type III N-terminal propeptide) and albuminuria. In adjusted analyses, each year of TDF exposure was independently associated with 3.3% higher interleukin-18 (95% CI: 0.8% to 5.8%), 3.4%...

10.1097/qai.0000000000001027 article EN JAIDS Journal of Acquired Immune Deficiency Syndromes 2016-04-19

&lt;b&gt;&lt;i&gt;Background:&lt;/i&gt;&lt;/b&gt; HIV-infected (HIV+) persons are at increased risk of chronic kidney disease, but serum creatinine does not detect early losses in function. We hypothesized that urine biomarkers damage would be associated with subsequent changes function a contemporary cohort HIV+ and HIV-uninfected (HIV–) men. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; In the Multicenter AIDS Cohort Study, we measured baseline concentrations 5 from 2009 to 2011 860 337...

10.1159/000502898 article EN American Journal of Nephrology 2019-01-01
Coming Soon ...